Screener
Harmony Biosciences Holdings, Inc. HRMY Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Investments, long-term | 229,555 | 107,127 |
| Intangible assets, net | 83,457 | 89,418 |
| Deferred tax asset | 153,562 | 149,699 |
| Other noncurrent assets | 26,433 | 18,373 |
| Total noncurrent assets | 493,007 | 364,617 |
| TOTAL ASSETS | $1,271,824 | $1,271,631 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
- Harmony Biosciences Holdings, Inc. (HRMY) reported deferred tax assets and other non-current assets of $26.43M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets increased by 345.1% year-over-year, from $5.94M to $26.43M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets has grown at a 160.9% compound annual growth rate (CAGR), from $152K to $18.37M.
Ask your AI about Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude